Nurse Practitioner, Family · Lafayette, LA
NPI
1720427966
Since 2013
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4809 Ambassador Caffery Pkwy Ste 420
Lafayette, LA, 70508
Phone (337) 470-6498
Groups this clinician bills Medicare through
Medicare paid, 2024
$113K
1,748 services
Medicare patients, 2024
447
Average age 71
Drug cost, 2024
$862K
715 prescriptions
Company payments, 2025
$135
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lindsi D Pizzolato was code 99232 (hospital e&m - subsequent), 809 times for 238 patients. In total Lindsi D Pizzolato billed 1,748 services in 7 codes, and Medicare paid $113K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 809 | 238 | $50.08 | $41K |
| 99213 Office E&M - Established | Office | 358 | 157 | $50.49 | $18K |
| 99223 Hospital E&M - Initial | Facility | 296 | 238 | $109.91 | $33K |
| 99214 Office E&M - Established | Office | 145 | 76 | $77.92 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 125 | 41 | $75.49 | $9,436 |
| 99204 Office E&M - New | Office | 14 | 14 | $98.61 | $1,381 |
By year: 2022 $60K for 1,041 services; 2023 $58K for 1,029 services; 2024 $113K for 1,748 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lindsi D Pizzolato prescribed most often to Medicare patients was Sodium Chloride (0.9 % Sodium Chloride), with 99 prescriptions and refills. In total Lindsi D Pizzolato wrote 715 Medicare prescriptions that cost $862K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sodium Chloride 0.9 % Sodium Chloride | 99 | 99 | 18 | $932 |
| Daptomycin Generic | 87 | 87 | 23 | $129K |
| Vancomycin Hcl Generic | 51 | 51 | 17 | $15K |
| Cefepime Hcl Generic | 50 | 50 | 16 | $5,739 |
| Diphenhydramine Hcl Generic | 37 | 37 | 32 | $67.02 |
| Ertapenem Ertapenem Sodium | 36 | 36 | 21 | $19K |
| Cefazolin Sodium Generic | 33 | 33 | Under 11 | $1,544 |
| Teflaro Ceftaroline Fosamil Acetate | 27 | 27 | Under 11 | $64K |
| Ceftriaxone Ceftriaxone Sodium | 26 | 26 | Under 11 | $5,256 |
| Ampicillin-Sulbactam Ampicillin Sod/Sulbactam Sod | 25 | 25 | Under 11 | $5,299 |
| Meropenem Generic | 24 | 24 | Under 11 | $7,708 |
| Ciprofloxacin-D5w Ciprofloxacin In 5 % Dextrose | 15 | 15 | Under 11 | $1,303 |
| Epclusa Sofosbuvir/Velpatasvir | 15 | 15 | Under 11 | $358K |
| Tivicay Dolutegravir Sodium | 14 | 14 | Under 11 | $31K |
| Doxycycline Hyclate Generic | 12 | 14 | Under 11 | $308 |
Brand drugs: 248 claims; generic drugs: 467 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lindsi D Pizzolato $135 ($135 in general payments such as food, travel and fees) from 4 companies. The largest payer was Paratek Pharmaceuticals, Inc. with $52.85.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.